Expression of tgf-β signaling genes in the normal, premalignant, and malignant human trophoblast: Loss of smad3 in choriocarcinoma cells

Biochemical and Biophysical Research Communications

Volumn 287, Issue 1, 2001, Pages 47-55

  Xu, G ^a   Chakraborty, C ^a   Lala, P K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Choriocarcinoma; Smad proteins; TGF receptors; Trophoblast; Tumor progression

Indexed keywords

MESSENGER RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CANCER CELL CULTURE; CHORIOCARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TROPHOBLAST;

EID: 0035860239     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5533     Document Type: Article

References (54)

1. Physiological actions and clinical applications of transforming growth factor-β (TGF-β)
2. TGF-β signal transduction
3. TGF-β signaling from cell membrane to nucleus through SMAD proteins
4. Spemann organizer of Smad10
5. TGF-β signaling from receptors to the nucleus
6. Controlling TGF-β signaling
7. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression
8. Acquisition of TGF-β1 resistance: An important progression factor in human renal cell carcinoma
9. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells
10. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
11. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
12. Mutations increasing autoinhibition inactivate tumor suppressors Smad2 and Smad4
13. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers
14. Mechanisms of placental invasion of the uterus and their control
15. Extravillous trophoblast in the human placenta. A review
16. Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: Growth pattern, markers and hormone production
17. Localization of transforming growth factor-β at the human fetal-maternal interface: Role in trophoblast growth and differentiation
18. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-β, IGF-II and IGFBP-1
19. Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells
20. Basement membrane invasion by first trimester human trophoblast: Requirement for branched complex-type oligosaccharides
21. Establishment and characterization of first trimester human trophoblast cells with extended life span
22. Mechanism of control of trophoblast invasion in situ
23. Resistance of malignant trophoblast cells to both anti-proliferation and anti-invasive effects of transforming growth factor-β
24. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyper-invasiveness and resistance to anti-invasive action to TGFβ
25. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in gap junctional intercellular communication
26. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β) induced growth inhibition and transcriptional response in breast tumour cells
27. Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma: Implications for roles of smads in its growth
28. Disruption of TGF β signaling pathways in human pancreatic cancer cells
29. Regulation of α-smooth muscle actin and CRBP-1 expression by retinoic acid and TGF-β in cultured fibroblasts
30. Structural and sequence analysis of TGF-β2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing
31. The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells
32. Induction of apoptosis by smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells
33. Effect of transforming growth factor-β on the plasminogen activator system in cultured first trimester human cytotrophoblast
34. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach
35. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between smads and Sp1
36. Director binding of smad3 and smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator-type 1 gene
37. Targeted disruption of smad3 reveals an essential role in transforming growth factor β-mediated signal transduction
38. Dominant-negative smad3 interferes with transcriptional activation by multiple agonists
39. Receptor-associated Mad homologues synergize as effectors of the TGF-β response
40. Samd2 and Smad3 positively and negatively regulate TGF-β dependent transcription through the forkhead DNA-binding protein FAST 2
41. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3
42. TGF-β signaling by Smad proteins
43. Negative feedback regulation of TGF-β signaling by SnoN onco-protein
44. Targeted mutations of transforming growth factor-β genes reveal important roles in mouse development and adult homeostasis
45. Smad3 mutant mice develop metastatic colorectal cancer
46. Smads in human trophoblast cells: Expression, regulation and role in TGF-β-induced transcriptional activity
47. Insulin-like growth factor binding protein-1 stimulates human trophoblast migration by signaling through α5β1 integrin via mitogen-activated protein kinase pathway
48. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis
49. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing
50. Transforming growth factor-β1 expression during placental development
51. Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation
52. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF-β3
53. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53 null mice is prognostic for a high risk of malignant conversion
54. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion